AirPods Pro 3 Vs. AirPods Pro 2: Which Wireless Earbuds Are Better?

Tech-news AirPods Pro, Apple, Apple Event, Audio September 9, 2025

After years of speculation, Apple’s AirPods Pro 3 are finally here, and while we haven’t tried them for ourselves, they look like they were worth the wait. This generation brings new hardware, features, and some impressive improvements on paper over the last generation, which was refreshed in 2023 with USB-C and a few other features. If you’re in the market for new AirPods, you’re probably already wondering whether you should rush out to scoop up Apple’s long-awaited third-gen, but before you do that, you should know what you’re getting into.

Luckily, we’re here to give you a categorical breakdown that shows all of this year’s improvements and what’s the same as the AirPods Pro 2. Have at it, folks.

AirPods Pro 3 vs. AirPods Pro 2: ANC

When it comes to AirPods Pro, ANC is one of the most important categories, and this year’s generation is no different. Apple knows that, which is why it clearly went back to the lab and took a stab at improving noise-canceling gen over gen.

According to Apple, AirPods Pro 3 use “ultra-low noise microphones and advanced computational audio” to help give this generation 2x more ANC than AirPods Pro 2. That equates to 4x more ANC than the original AirPods Pro. It’s not all ANC, though. Apple says that this year’s earbuds should also improve passive noise cancellation, thanks to new ear tips that are filled with foam, creating a better seal in your ears.

Apple doesn’t provide specific numbers for how many dBs are cancelled by its earbuds, but from the sounds of it, AirPods Pro 3 should excel in the ANC department and maybe even give Bose’s QuietComfort Ultra earbuds (my favorite buds for ANC) a run for their money.

AirPods Pro 3 vs. AirPods Pro 2: Sound

Apple AirPods Pro 3 Hero 250909 Inline.jpg.large 2x — © Apple

I haven’t gotten to listen to AirPods Pro 3 myself yet, but Apple says its new generation boasts some improvements over the AirPods Pro 2. Behind that is a tweak to the AirPods Pro 3 architecture.

According to Apple, the AirPods Pro 3 have a “multiport acoustic architecture” that better controls the airflow and the way the sound carries to the ear. Apple couples that with a new Adaptive EQ, which is designed to give the AirPods Pro 3 a better bass response and widen the soundstage. Again, this all sounds good in theory, but we’ve yet to hear them for ourselves. On paper, at least, Apple’s AirPods 3 should be the best-sounding AirPods you can buy right now.

AirPods Pro 3 vs. AirPods Pro 2: Battery

Battery life is one of the biggest metrics of any good pair of wireless earbuds, and, again, AirPods Pro 3 roll the ball forward here. According to Apple, the AirPods Pro 3 now have 8 hours of playback with ANC on as opposed to the 6-hour average of the AirPods Pro 2. If you want to extend the battery life even longer, you can listen to the AirPods Pro 3 with transparency on (ANC off), and you’ll get 10 hours of battery life on a single charge, according to Apple.

There’s really no subjectivity here—more battery is just better—but if you’re curious, the AirPods Pro 3 improve upon the AirPods Pro 2 battery by 33 percent when it comes to ANC playback. On top of that, I’d say that AirPods Pro 3 also beat a lot of its non-Apple competition, which usually averages around 6 hours of battery with ANC on.

AirPods Pro 3 vs. AirPods Pro 2: Features

A person rides a train while wearing Apple AirPods 3. — © Apple

If you’re picking up on a trend, it’s that AirPods Pro 3 are pretty much better across the board, but this is where they really start to pull away. There are some things in the third-gen AirPods Pro that the AirPods Pro 2 just can’t do. One of those things is heart rate monitoring. Thanks to new IR sensors in the AirPods Pro 3, which are combined with the preexisting accelerometer, gyroscope, and GPS, these earbuds can track fitness goals, calories burned, and heart rate. According to Apple, AirPods Pro 3 will combine with its suite of fitness tools, allowing Apple Fitness+ users to see real-time performance metrics onscreen. And yes, unlike the PowerBeats Pro 2, you can listen to music while you track your health metrics.

Another exclusive feature with the AirPods Pro 3 is Live Translation, which does exactly what it sounds like—it translates speech in real time. One cool aspect of the AirPods Pro 3 translation feature is that it uses ANC to lower the voice of the person you’re talking to so you can actually hear the translation in your earbuds. While the feature is still in beta, Apple says you can currently use Live Translation for English, French, German, Portuguese, and Spanish, and Italian, Japanese, Korean, and Chinese are on the way.

That’s all to say that you’ll be able to do basically everything you can do with AirPods Pro 2 with the AirPods Pro 3—adaptive ANC, hearing test (though the AirPods Pro 3 is allegedly better at that), transparency, and more—but with two big new features in heart rate tracking and Live Translation. Point goes to AirPods Pro 3 once again.

AirPods Pro 3 vs. AirPods Pro 2: Comfort

Airpods Pro 2 Statue Of Liberty 1 — © Photo: Kyle Barr / Gizmodo

Comfort is another huge metric for earbuds, especially if you plan to wear them for long periods or while you’re exercising. Once more, Apple seems to have taken strides here with its new generation of AirPods. While both earbuds have ear tips, Apple says that it used “over 10,000 ear scans with more than 100,000 hours of user research” to tweak the fit of AirPods Pro 3.

Specifically, Apple says the “external geometry of the ear tip” now aligns to the center of the body for more stability. AirPods Pro 3 also come with five ear tip sizes as opposed to four. With more sizes and a redesign, it looks like AirPods Pro 3 are poised to outpace the AirPods Pro 2 in comfort, too.

AirPods Pro 3 vs. AirPods Pro 2: Price

So, there is one thing that’s the same on these two pairs of earbuds, and while that sounds like a point against the AirPods Pro 3, it’s actually a big win for Apple’s newest pair of AirPods. Both pairs debuted at $250, and while you can currently get the AirPods Pro 2 for $200, AirPods Pro 3 still qualify as a static entry price gen over gen. More for the same amount! Nice!

Source link
#AirPods #Pro #AirPods #Pro #Wireless #Earbuds

Tag AirPods Pro Apple Apple Event Audio

11 Unexpected Ways To Style An Oversized Shirt

#Luna #Introduces #Luna #Band #RealTime #Health #Tracking #FeaturesLuna">

mwasimuddin125 0

officially unveiled the Luna Band, a new voice-first wearable designed to help users improve their daily routines through real-time health tracking. Supported by the company’s LifeOS intelligence system, the wearable continuously monitors body signals and transforms them into personalized recommendations. Luna designed the device for people who want smarter support for productivity, recovery, and overall health. The invite-only Drop 1 is expected to begin shipping by the end of July 2026.

Luna Band: Key Highlights

Luna designed the Luna app to make health tracking simpler and more organized by consolidating several wellness features into a single platform. This app integrates features that involve stress management, nutrition, exercise, supplements, and recovery into a single application. Another customization option available to users is creating personal health modules in the app.

The application brings together aspects of stress, diet, fitness, nutritional supplements, and productivity within the app’s micro-apps. Users can also sync third-party devices and other relevant health-related data sources for a more personalized experience.

The company also allows users to create their own health modules in the app rather than relying solely on prebuilt features. Alongside this, Luna highlights its voice-logging feature, which eliminates the need for manual data entry. Users can quickly record meals, workouts, and daily habits through simple voice commands, making health tracking faster.

Luna designed LifeOS as one of its main AI-powered features to simplify health tracking through personalized insights and recommendations. The system continuously studies body signals, lifestyle habits, biomarkers, and health trends to deliver a better understanding of overall wellness. Luna says LifeOS is included with the Luna Band platform.

Price and Availability

Luna has confirmed that the first release of the Luna Band, called Drop 1, will be available through an invite-only system. Users interested in the wearable can sign up through the company’s official waitlist before shipping starts later in July 2026.

#Luna #Introduces #Luna #Band #RealTime #Health #Tracking #FeaturesLuna">Luna Introduces Luna Band With Real-Time Health Tracking Features

Luna has officially unveiled the Luna Band, a new voice-first wearable designed to help users improve their daily routines through real-time health tracking. Supported by the company’s LifeOS intelligence system, the wearable continuously monitors body signals and transforms them into personalized recommendations. Luna designed the device for people who want smarter support for productivity, recovery, and overall health. The invite-only Drop 1 is expected to begin shipping by the end of July 2026.

Luna Band: Key Highlights

Price and Availability

#Luna #Introduces #Luna #Band #RealTime #Health #Tracking #FeaturesLuna

Can Ozempic Treat Alcoholism? Here’s What You Should Know
Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

© Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

© Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too. #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As — © siamionau pavel via Shutterstock

The obesity medication Saxenda, made with liraglutide — © siamionau pavel via Shutterstock

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">

mwasimuddin125 0

suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">Can Ozempic Treat Alcoholism? Here’s What You Should Know

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders.

Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic — © Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As

Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping">

mwasimuddin125 0

Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)
Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.
You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Save 15% (Or More) When You Purchase a Cocktail Bundle

Bartesian Rewards Club: Get More for Your Buck

Earn 2,500 Points and Give $25 When You Refer a Friend

#Top #Bartesian #Discount #Codescoupons,shopping">Top Bartesian Discount Codes: 35% Off

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Save 15% (Or More) When You Purchase a Cocktail Bundle

Bartesian Rewards Club: Get More for Your Buck

Earn 2,500 Points and Give $25 When You Refer a Friend

#Top #Bartesian #Discount #Codescoupons,shopping

AirPods Pro 3 vs. AirPods Pro 2: ANC

AirPods Pro 3 vs. AirPods Pro 2: Sound

AirPods Pro 3 vs. AirPods Pro 2: Battery

AirPods Pro 3 vs. AirPods Pro 2: Features

AirPods Pro 3 vs. AirPods Pro 2: Comfort

AirPods Pro 3 vs. AirPods Pro 2: Price

11 Unexpected Ways To Style An Oversized Shirt

‘Dopamine Devices’: The Growing Movement to Have Cellphones Banned from Public Schools

Related Posts

Luna Band: Key Highlights

Price and Availability

Luna Band: Key Highlights

Price and Availability

Save up to 35% With a Bartesian Cocktail Subscription

Save 15% (Or More) When You Purchase a Cocktail Bundle

Bartesian Rewards Club: Get More for Your Buck

Earn 2,500 Points and Give $25 When You Refer a Friend

Save up to 35% With a Bartesian Cocktail Subscription

Save 15% (Or More) When You Purchase a Cocktail Bundle

Bartesian Rewards Club: Get More for Your Buck

Earn 2,500 Points and Give $25 When You Refer a Friend

Post Comment Cancel reply